Novel cyclic tetrapeptide derivatives and pharmaceutical use thereof
CA 2362817 A1 · Owner: Horinouchi, Sueharu · Inventors: Komatsu, Yasuhiko; Yoshida, Minoru; Nishino, Norikazu
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cyclic tetrapeptide derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof: (wherein R21 and R22 are each independently hydrogen, linear C1-C6 alkyl to which a nonaromatic cycloalkyl group or an optionally substituted aromatic ring may be bonded or branched C3-, C6 alkyl to which a nonaromatic cycloalkyl group or an optionally substituted aromatic ring may be bonded; and R1 and R3 are each independently linear C1-C5 alkylene which may have a C1-C6 side chain and the side chain may form a , fused ring structure on the alkylene chain). Histone deacetylase inhibitors MHC class I molecule development promotors and drug compositions containing , as the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.